Menü
You need to sign in or sign up before continuing.
Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

Blog

After Plummeting Over 30%, Are Arcturus Therapeutics Shares Still a Good Buy?
After Plummeting Over 30%, Are Arcturus Therapeutics Shares Still a Good Buy?

Arcturus Therapeutics' (NASDAQ: ARCT) stock saw deep losses on May 27, in part because of spillover from news about patients in Moderna's (NASDAQ: MRNA) COVID-19 vaccine trial experiencing adverse

3 Cannabis Stocks to Avoid Like the Plague in June
3 Cannabis Stocks to Avoid Like the Plague in June

For years, marijuana stocks were viewed by investors as the greatest thing since sliced bread. With the legal pot industry generating $10.9 billion in worldwide sales in 2018, and Wall Street

3 Factors in Determining Your Ideal Retirement Age
3 Factors in Determining Your Ideal Retirement Age

Choosing the age at which you finally retire is one of the most important decisions you'll make, but it can be a difficult question to answer.

What you don't want to do is pick an age that sounds

Why Aurora Cannabis Stock Soared 59% in May
Why Aurora Cannabis Stock Soared 59% in May

Shares of Aurora Cannabis (NYSE: ACB) surged 59% last month, according to data provided by S&P Global Market Intelligence. The marijuana producer delivered better-than-expected third-quarter results

Could This Obscure Biotech Stock Make Early Investors a Fortune?Photo, wide shot, wide-angle lens,  Biotech company, Blue hour, twilight, cool, ISO1200, slow shutter speed, photo by Sebastião Salgado: https://img.theapi.app/temp/80e18bfd-1ff8-4487-af62-1cdb7de1ceb6.png
Could This Obscure Biotech Stock Make Early Investors a Fortune?

Plenty of promising biotech stocks on the market right now have slipped under the radar thanks to the COVID-19 pandemic. Akero Therapeutics (NASDAQ: AKRO) is one such company. Founded back in 2017

Is Berkshire Hathaway a Buy While It's Down?
Is Berkshire Hathaway a Buy While It's Down?

The stock market has rebounded nicely. After plunging by about 40% from its record highs in March as the COVID-19 pandemic worsened, the S&P 500 is now about 5% shy of where it started the year.

One

Why LivePerson Shares Rose 56% Last MonthPhoto, wide shot, wide-angle lens,  Telecom equipment supplier, Midday, harsh overhead sunlight, directional sunlightt, photo by Thomas Heaton: https://img.theapi.app/temp/3967c11c-b755-4d39-87d0-acc853384c80.png
Why LivePerson Shares Rose 56% Last Month

Shares of LivePerson (NASDAQ: LPSN) gained 56.4% in May 2020, according to data from S&P Global Market Intelligence. The maker of AI-powered chatbots and highly automated business communication

Zynga Doubles Down on the Future With $1.8 Billion Acquisition
Zynga Doubles Down on the Future With $1.8 Billion Acquisition

Zynga (NASDAQ: ZNGA) has been very successful in recent years using acquisitions to fuel its revenue growth. Since 2011, Zynga has spent billions on these acquisitions, typically with small-size

Better Buy: Bristol Myers Squibb vs. Gilead Sciences
Better Buy: Bristol Myers Squibb vs. Gilead Sciences

There are few names more well-known in the biopharmaceutical world than Bristol Myers Squibb (NYSE: BMY) and Gilead Sciences (NASDAQ: GILD). While neither stock was immune to the coronavirus bear

3 Tricks to Help You Save on Your Taxes for Next Year
3 Tricks to Help You Save on Your Taxes for Next Year

I know: You probably have a lot on your mind and don't want to think about taxes until you absolutely have to. But it's actually to your benefit to start thinking about your 2020 taxes now, even if

3 ETFs Perfect for Your IRA
3 ETFs Perfect for Your IRA

Legendary investor Warren Buffett has said several times that the best way for the average American to invest isn't to buy individual stocks, but to simply invest in low-cost, passive index funds

Biotech Stocks: Buy This, Not ThatPhoto, wide shot, wide-angle lens,  Clinical research organization, Blue hour, twilight, cool, ISO1200, slow shutter speed, photo by David Maisel: https://img.theapi.app/temp/0e9d087d-988e-4397-b7cf-6049e2776769.png
Biotech Stocks: Buy This, Not That

A crucial aspect of success in investing in biotech stocks is that of timing. Buying a stock too early can mean enduring infinite dilution and clinical trial failures before a company can finally

2 Bargain Stocks You Can Buy Today
2 Bargain Stocks You Can Buy Today

The stock market has rallied sharply since crashing in March. Although the S&P 500 was down by roughly 40% from all-time highs at the depths of the plunge, it is now within shouting distance of

Could the Rush to a Vaccine Hurt Coronavirus Stocks?
Could the Rush to a Vaccine Hurt Coronavirus Stocks?

Nearly 6.2 million people worldwide are confirmed to have contracted COVID-19, more than 376,000 people have died, and the pandemic is far from over.  So with containment of the coronavirus pandemic

Unemployed Due to COVID-19? Here's How It Could Affect Your Social Security Benefits
Unemployed Due to COVID-19? Here's How It Could Affect Your Social Security Benefits

In April, the U.S. unemployment rate reached 14.7%, its worst on record since the Great Depression. And while May data hasn't been released as of this writing, it's safe to say that we have a

Here's Why Livongo Health Rocketed 49.8% Higher in May
Here's Why Livongo Health Rocketed 49.8% Higher in May

Shares of Livongo Health (NASDAQ: LVGO), a digital health company, jumped 49.8% in May, according to data from S&P Global Market Intelligence. A glowing first-quarter earnings report provided

3 Top E-Commerce Stocks to Buy in June
3 Top E-Commerce Stocks to Buy in June

There's little doubt that the trend toward e-commerce had taken hold long before COVID-19 reared its ugly head, but there's overwhelming evidence that the trend has experienced significant

Buffett's Portfolio Hasn't Done This in 4 Years, Until Now
Buffett's Portfolio Hasn't Done This in 4 Years, Until Now

For the past five-plus decades, Berkshire Hathaway (NYSE: BRK.A)(NYSE: BRK.B) CEO Warren Buffett has been in a class of his own on the investing front. According to Berkshire Hathaway's annual

This is the Single Biggest Retirement Savings Mistake You Can Make
This is the Single Biggest Retirement Savings Mistake You Can Make

Saving enough to retire can seem difficult, especially during these financially turbulent times. Unfortunately, many people make it harder than it needs to be with a costly mistake: waiting to start

Zoom Stock Keeps Skyrocketing Higher
Zoom Stock Keeps Skyrocketing Higher

Shares of videoconferencing company Zoom Video Communications (NASDAQ: ZM) jumped higher on Wednesday, climbing about 8%. The stock's gain adds to a torrid year-to-date run-up. Shares are now up

Better Buy: Disney vs. Chipotle
Better Buy: Disney vs. Chipotle

Comparing Disney (NYSE: DIS) and Chipotle Mexican Grill (NYSE: CMG) might seem like comparing apples and oranges, but from an investment perspective, it doesn't make a difference. I consider both

Elastic N V (ESTC) Q4 2020 Earnings Call Transcript
Elastic N V (ESTC) Q4 2020 Earnings Call Transcript

Image source: The Motley Fool.

Elastic N V (NYSE: ESTC)Q4 2020 Earnings CallJun 03, 2020, 5:00 p.m. ET

Operator

Continue reading

Source Fool.com

Smartsheet Inc (SMAR) Q1 2020 Earnings Call Transcript
Smartsheet Inc (SMAR) Q1 2020 Earnings Call Transcript

Image source: The Motley Fool.

Smartsheet Inc (NYSE: SMAR)Q1 2020 Earnings CallJun 3, 2020, 4:30 p.m. ET

Operator

Continue reading

Source Fool.com

Cloudera, Inc. (CLDR) Q1 2021 Earnings Call Transcript
Cloudera, Inc. (CLDR) Q1 2021 Earnings Call Transcript

Image source: The Motley Fool.

Cloudera, Inc. (NYSE: CLDR)Q1 2021 Earnings CallJun 3, 2020, 5:00 p.m. ET

Operator

Continue reading

Source Fool.com

Why Ubiquiti Stock Rose 13.8% in May
Why Ubiquiti Stock Rose 13.8% in May

Shares of Ubiquiti (NYSE: UI) rose 13.8% during the month of May, according to data from S&P Global Market Intelligence. The networking equipment vendor delivered a better-than-expected earnings